{"id":17,"date":"2026-06-11T12:32:28","date_gmt":"2026-06-11T10:32:28","guid":{"rendered":"https:\/\/publichealthtribune.com\/tr\/2026\/06\/11\/covid-19-asisi-hamilelik-sirasinda-anne-veya-bebek-icin-artmis-risk-tasimiyor\/"},"modified":"2026-06-11T12:33:11","modified_gmt":"2026-06-11T10:33:11","slug":"covid-19-asisi-hamilelik-sirasinda-anne-veya-bebek-icin-artmis-risk-tasimiyor","status":"publish","type":"post","link":"https:\/\/publichealthtribune.com\/tr\/2026\/06\/11\/covid-19-asisi-hamilelik-sirasinda-anne-veya-bebek-icin-artmis-risk-tasimiyor\/","title":{"rendered":"COVID-19 A\u015f\u0131s\u0131 Hamilelik S\u0131ras\u0131nda Anne veya Bebek \u0130\u00e7in Artm\u0131\u015f Risk Ta\u015f\u0131m\u0131yor"},"content":{"rendered":"

COVID-19 A\u015f\u0131s\u0131 Hamilelik S\u0131ras\u0131nda Anne veya Bebek \u0130\u00e7in Artm\u0131\u015f Risk Ta\u015f\u0131m\u0131yor<\/h1>\n

Pfizer-BioNTech\u2019in mRNA COVID-19 a\u015f\u0131s\u0131yla a\u015f\u0131lanan 450.000\u2019den fazla hamile kad\u0131n\u0131 kapsayan 25 \u00e7al\u0131\u015fman\u0131n derinlemesine analizi, g\u00fcvence verici sonu\u00e7lar ortaya koyuyor. D\u00fc\u015f\u00fck, do\u011fumsal anomali, erken do\u011fum, hipertansif bozukluklar, gestasyonel ya\u015fa g\u00f6re d\u00fc\u015f\u00fck do\u011fum a\u011f\u0131rl\u0131\u011f\u0131, d\u00fc\u015f\u00fck do\u011fum a\u011f\u0131rl\u0131\u011f\u0131 veya yenido\u011fan \u00f6l\u00fcm\u00fc riskinde herhangi bir art\u0131\u015f g\u00f6zlenmedi. Sonu\u00e7lar, a\u015f\u0131laman\u0131n ilk, ikinci veya \u00fc\u00e7\u00fcnc\u00fc \u00fc\u00e7 ayl\u0131k d\u00f6nemde yap\u0131l\u0131p yap\u0131lmad\u0131\u011f\u0131na veya al\u0131nan doz say\u0131s\u0131na ba\u011fl\u0131 olarak tutarl\u0131 kal\u0131yor.<\/p>\n

Hamile kad\u0131nlar, COVID-19\u2019un a\u011f\u0131r formlar\u0131na kar\u015f\u0131 \u00f6zellikle savunmas\u0131z olup, yo\u011fun bak\u0131m yat\u0131\u015f\u0131 ve obstetrik komplikasyonlar riski daha y\u00fcksektir. Bununla birlikte, fet\u00fcs veya bebek i\u00e7in g\u00fcvenlik endi\u015feleri nedeniyle a\u015f\u0131 teredd\u00fct\u00fc devam etmektedir. \u00c7e\u015fitli g\u00f6zlemsel veriler temelinde yap\u0131lan bu sistematik inceleme, a\u015f\u0131n\u0131n anne veya bebek i\u00e7in ciddi yan etkilere neden olmad\u0131\u011f\u0131n\u0131 do\u011fruluyor.<\/p>\n

Dahil edilen \u00e7al\u0131\u015fmalar, \u00e7e\u015fitli n\u00fcfuslar\u0131 ve farkl\u0131 sa\u011fl\u0131k sistemlerini kaps\u0131yor ve metodolojilerinde \u00e7e\u015fitlilik g\u00f6steriyor: ulusal kay\u0131tlar, prospektif veya retrospektif kohortlar. Bu farkl\u0131l\u0131klara ra\u011fmen, etki tahminleri n\u00f6trale yak\u0131n kal\u0131yor ve herhangi bir uyar\u0131 sinyali bulunmuyor. \u00d6rne\u011fin, a\u015f\u0131lanan kad\u0131nlarda do\u011fumsal anomali oranlar\u0131, genel n\u00fcfusunkine benzer \u015fekilde seyrediyor ve a\u015f\u0131 ile 37. haftadan \u00f6nce do\u011fum aras\u0131nda herhangi bir ba\u011flant\u0131 kurulmad\u0131.<\/p>\n

Baz\u0131 s\u0131n\u0131rlamalar devam etmekte, \u00f6rne\u011fin ilk \u00fc\u00e7 ayl\u0131k d\u00f6nemde maruziyetler veya son derece nadir olaylar hakk\u0131nda kesin verilerin eksikli\u011fi. Bununla birlikte, var olan b\u00fcy\u00fck ulusal \u00e7al\u0131\u015fmalar, erken a\u015f\u0131lamayla ilgili \u00f6zel bir sorun ortaya koymad\u0131. Sonu\u00e7lar\u0131n veya maruziyet pencerelerinin tan\u0131m\u0131ndaki farkl\u0131l\u0131klar, genel sonucu sorgulamad\u0131: bu a\u015f\u0131, hamilelik s\u0131ras\u0131nda sa\u011flam bir g\u00fcvenlik profili sunuyor.<\/p>\n

Bu sentez, hamile kad\u0131nlar\u0131n a\u015f\u0131lanmas\u0131n\u0131 te\u015fvik eden sa\u011fl\u0131k \u00f6nerilerini g\u00fc\u00e7lendiriyor. Sa\u011fl\u0131k profesyonellerine, hamilelikleri veya bebekleri i\u00e7in kan\u0131tlanm\u0131\u015f bir risk olmad\u0131\u011f\u0131n\u0131 garantileyerek hastalar\u0131 rahatlatma imkan\u0131 sunuyor ve ayn\u0131 zamanda enfeksiyondan korunman\u0131n \u00f6nemini vurguluyor; zira enfeksiyonun kendisi kan\u0131tlanm\u0131\u015f tehlikeler ta\u015f\u0131yor. Mevcut kan\u0131tlar, g\u00f6zlemsel olsa da, bu koruyucu yakla\u015f\u0131m\u0131 desteklemek i\u00e7in yeterince sa\u011flamd\u0131r.<\/p>\n

\n

\u00c0 propos de nos sources<\/h2>\n

Publication originale<\/h3>\n

DOI\u00a0:<\/strong> https:\/\/doi.org\/10.1007\/s40121-026-01378-5<\/a><\/p>\n

Titre\u00a0:<\/strong> Safety of BNT162b2 COVID-19 Vaccine in Pregnancy: A Systematic Review<\/p>\n

Revue : <\/strong> Infectious Diseases and Therapy<\/p>\n

\u00c9diteur : <\/strong> Springer Science and Business Media LLC<\/p>\n

Auteurs : <\/strong> Elizabeth Thoburn; Vassilis G. Giannakoulis; Tianyan Hu; Henry Goebe; Sheetal Raina; Mary M. Moran; Benedicte Perreault; Luis Val-Maranes; Evelyn Barron Millar; Isabelle Whittle; Fiona Pearson; Santiago M. C. Lopez<\/p>\n","protected":false},"excerpt":{"rendered":"

COVID-19 A\u015f\u0131s\u0131 Hamilelik S\u0131ras\u0131nda Anne veya Bebek \u0130\u00e7in Artm\u0131\u015f Risk Ta\u015f\u0131m\u0131yor Pfizer-BioNTech\u2019in mRNA COVID-19 a\u015f\u0131s\u0131yla a\u015f\u0131lanan 450.000\u2019den fazla hamile kad\u0131n\u0131 kapsayan 25 \u00e7al\u0131\u015fman\u0131n derinlemesine analizi, g\u00fcvence verici sonu\u00e7lar ortaya koyuyor. D\u00fc\u015f\u00fck, do\u011fumsal anomali, erken do\u011fum, hipertansif bozukluklar, gestasyonel ya\u015fa g\u00f6re d\u00fc\u015f\u00fck do\u011fum a\u011f\u0131rl\u0131\u011f\u0131, d\u00fc\u015f\u00fck do\u011fum a\u011f\u0131rl\u0131\u011f\u0131 veya yenido\u011fan \u00f6l\u00fcm\u00fc riskinde herhangi bir art\u0131\u015f g\u00f6zlenmedi. Sonu\u00e7lar,… Okumaya devam et COVID-19 A\u015f\u0131s\u0131 Hamilelik S\u0131ras\u0131nda Anne veya Bebek \u0130\u00e7in Artm\u0131\u015f Risk Ta\u015f\u0131m\u0131yor<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,2],"tags":[],"class_list":["post-17","post","type-post","status-publish","format-standard","hentry","category-kultur","category-saglik","entry"],"_links":{"self":[{"href":"https:\/\/publichealthtribune.com\/tr\/wp-json\/wp\/v2\/posts\/17","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/publichealthtribune.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/publichealthtribune.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/publichealthtribune.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/publichealthtribune.com\/tr\/wp-json\/wp\/v2\/comments?post=17"}],"version-history":[{"count":1,"href":"https:\/\/publichealthtribune.com\/tr\/wp-json\/wp\/v2\/posts\/17\/revisions"}],"predecessor-version":[{"id":18,"href":"https:\/\/publichealthtribune.com\/tr\/wp-json\/wp\/v2\/posts\/17\/revisions\/18"}],"wp:attachment":[{"href":"https:\/\/publichealthtribune.com\/tr\/wp-json\/wp\/v2\/media?parent=17"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/publichealthtribune.com\/tr\/wp-json\/wp\/v2\/categories?post=17"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/publichealthtribune.com\/tr\/wp-json\/wp\/v2\/tags?post=17"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}